Vaxcyte
Brad Beres is a highly experienced quality control professional with a strong background in method validation and transfer, currently serving as the Senior Quality Control Manager at Vaxcyte since January 2024. Previously, Brad held the position of Senior Scientist at Pfizer from July 2021 to December 2023, where key responsibilities included coordinating method transfer and validation activities globally, preparing and reviewing critical technical documents, and providing GMP documentation in support of BLA filings. Prior roles include QC Supervisor at Novartis Gene Therapies, where oversight of laboratory activities and project management were critical, as well as positions at Pfizer and Colorado Serum Company focusing on extensive analytical testing in compliance with cGMP protocols. Brad's academic credentials include a Bachelor of Science in Biology and a Bachelor of Science in Wildlife Biology from the University of Georgia.
This person is not in any teams
This person is not in any offices
Vaxcyte
2 followers
Vaxcyte, formerly known as SutroVax, is a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.